10 Hot Storage Startups to Watch – 20 Finalists

Related Posts

26 Nov

Middleton Samaritan hopes to see again

After stopping to help someone on the freeway, and getting hit himself, Jamie Harrell spent about two months in…

read more
30 Jun

Specs help give Brian gift of sight

Brian Casey who lives off Poulton Road, thought he would never see again after losing his sight nearly 27…

read more
05 Jan

15 Pittsburgh tech companies to watch in 2021

CytoAgents on list of top 15 Pittsburgh tech companies to watch in 2021. Read more >>

read more
26 Apr

ICM invests in alternative aquafeed firm KnipBio

Biotechnology company KnipBio announced on 23 April that it has entered into a Joint Development Agreement with ICM Inc….

read more
05 Oct

Why Corbus Pharmaceuticals Holdings Inc Shares Skyrocketed Today

Corbus Pharmaceuticals (NASDAQ: CRBP) is up 29% at 1:18 p.m. EDT after an analyst at Cantor Fitzgerald initiated coverage…

read more
19 Nov

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods

Silo Pharma, Inc. a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that…

read more
22 Apr

Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE) Study

Hoth Therapeutics, Inc., a biopharmaceutical company, today announced top line data from its Cutaneous Lupus Erythematosus (CLE) study, a…

read more
20 Aug

Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at…

read more
29 Jun

Platelet BioGenesis Receives $3.5 Million Grant from Department of Defense

Cambridge, Massachusetts-based Platelet Biogenesis was awarded a two-year, $3.5 million grant from the U.S. Department of Defense. The funds…

read more
29 Jul

Siamab Therapeutics Announces Publication in PLOS ONE of Positive Data from Preclinical Studies of its ST1 Antibody Therapeutic in Development for Ovarian Cancer

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced the publication of positive preclinical data…

read more